Benchmark analyst Nathan Martin maintains CSX (NASDAQ:CSX) with a Buy and lowers the price target from $36 to $35.
GE HealthCare Techs’ Debt Overview
Over the past three months, shares of GE HealthCare Techs Inc. (NASDAQ:GEHC) increased by 6.09%. Before having a…